In any case, most of the GEP-NET patients that we studied did not express PD-L1 either on the tumor cells or peritumoral cells and the low percentage of positive tumors could be related to the reasons described above regarding IHC issues and to the low number of G3 tumors in our cohort37. This evidence concerns the gene CD274 and neoplasm.